Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice

Hidetaka Sasaki, Makiko Kobayashi, Richard B. Pollard, Fujio Suzuki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To investigate the effects of Z-100, an arabinomannan extracted from Mycobacterium tuberculosis, on the LP-BM5 murine leukemia virus (LP-BM5 MuLV) infection in mice. Methods: C57BL/6 mice infected intraperitoneally with 4.5 × 102 PFU/mouse of LP-BM5 MuLV (MAIDS mice) were treated intraperitoneally with a 10-mg/kg dose of Z-100 every other day beginning 1 day after the viral infection. MAIDS mice treated with Z-100 were compared with control mice (MAIDS mice treated with saline) for their survival and splenomegaly after LP-BM5 infection. Cytokine-producing profiles of splenic T cells from these two groups of mice were also compared. Results: When MAIDS mice treated with Z-100 were compared with those of control mice, a decrease in splenomegaly and lymphadenopathy was observed. Splenomegaly was markedly enhanced in MAIDS mice treated intraperitoneally with IL-4 or IL-10. When MAIDS mice were treated with Z-100, their survival rates were significantly increased compared to those of controls. Splenic T cells from control mice produced type-2 cytokines (IL-4 and IL-10). However, a decreased production of type-2 cytokines by splenic T cells from MAIDS mice treated with Z-100 was demonstrated. Conclusion: Z-100 could decrease the severity of the LP-BM5 MuLV infection through the regulation of MAIDS-associated type-2 T-cell responses.

Original languageEnglish (US)
Pages (from-to)96-103
Number of pages8
JournalPathobiology
Volume69
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Murine Leukemia Viruses
Virus Diseases
Murine Acquired Immunodeficiency Syndrome
Viruses
Mycobacterium tuberculosis
T-cells
Cytokines
Interleukin-4
Interleukin-10
Splenomegaly
T-Lymphocytes
specific substance maruyama
arabinomannan
Inbred C57BL Mouse

Keywords

  • AIDS
  • Murine AIDS
  • Type-2 T-cell responses
  • Z-100

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Biochemistry
  • Immunology and Allergy
  • Cell Biology

Cite this

Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. / Sasaki, Hidetaka; Kobayashi, Makiko; Pollard, Richard B.; Suzuki, Fujio.

In: Pathobiology, Vol. 69, No. 2, 2001, p. 96-103.

Research output: Contribution to journalArticle

Sasaki, Hidetaka ; Kobayashi, Makiko ; Pollard, Richard B. ; Suzuki, Fujio. / Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. In: Pathobiology. 2001 ; Vol. 69, No. 2. pp. 96-103.
@article{d903cad0583844ec93778e5954d01d76,
title = "Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice",
abstract = "Objective: To investigate the effects of Z-100, an arabinomannan extracted from Mycobacterium tuberculosis, on the LP-BM5 murine leukemia virus (LP-BM5 MuLV) infection in mice. Methods: C57BL/6 mice infected intraperitoneally with 4.5 × 102 PFU/mouse of LP-BM5 MuLV (MAIDS mice) were treated intraperitoneally with a 10-mg/kg dose of Z-100 every other day beginning 1 day after the viral infection. MAIDS mice treated with Z-100 were compared with control mice (MAIDS mice treated with saline) for their survival and splenomegaly after LP-BM5 infection. Cytokine-producing profiles of splenic T cells from these two groups of mice were also compared. Results: When MAIDS mice treated with Z-100 were compared with those of control mice, a decrease in splenomegaly and lymphadenopathy was observed. Splenomegaly was markedly enhanced in MAIDS mice treated intraperitoneally with IL-4 or IL-10. When MAIDS mice were treated with Z-100, their survival rates were significantly increased compared to those of controls. Splenic T cells from control mice produced type-2 cytokines (IL-4 and IL-10). However, a decreased production of type-2 cytokines by splenic T cells from MAIDS mice treated with Z-100 was demonstrated. Conclusion: Z-100 could decrease the severity of the LP-BM5 MuLV infection through the regulation of MAIDS-associated type-2 T-cell responses.",
keywords = "AIDS, Murine AIDS, Type-2 T-cell responses, Z-100",
author = "Hidetaka Sasaki and Makiko Kobayashi and Pollard, {Richard B.} and Fujio Suzuki",
year = "2001",
doi = "10.1159/000048762",
language = "English (US)",
volume = "69",
pages = "96--103",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice

AU - Sasaki, Hidetaka

AU - Kobayashi, Makiko

AU - Pollard, Richard B.

AU - Suzuki, Fujio

PY - 2001

Y1 - 2001

N2 - Objective: To investigate the effects of Z-100, an arabinomannan extracted from Mycobacterium tuberculosis, on the LP-BM5 murine leukemia virus (LP-BM5 MuLV) infection in mice. Methods: C57BL/6 mice infected intraperitoneally with 4.5 × 102 PFU/mouse of LP-BM5 MuLV (MAIDS mice) were treated intraperitoneally with a 10-mg/kg dose of Z-100 every other day beginning 1 day after the viral infection. MAIDS mice treated with Z-100 were compared with control mice (MAIDS mice treated with saline) for their survival and splenomegaly after LP-BM5 infection. Cytokine-producing profiles of splenic T cells from these two groups of mice were also compared. Results: When MAIDS mice treated with Z-100 were compared with those of control mice, a decrease in splenomegaly and lymphadenopathy was observed. Splenomegaly was markedly enhanced in MAIDS mice treated intraperitoneally with IL-4 or IL-10. When MAIDS mice were treated with Z-100, their survival rates were significantly increased compared to those of controls. Splenic T cells from control mice produced type-2 cytokines (IL-4 and IL-10). However, a decreased production of type-2 cytokines by splenic T cells from MAIDS mice treated with Z-100 was demonstrated. Conclusion: Z-100 could decrease the severity of the LP-BM5 MuLV infection through the regulation of MAIDS-associated type-2 T-cell responses.

AB - Objective: To investigate the effects of Z-100, an arabinomannan extracted from Mycobacterium tuberculosis, on the LP-BM5 murine leukemia virus (LP-BM5 MuLV) infection in mice. Methods: C57BL/6 mice infected intraperitoneally with 4.5 × 102 PFU/mouse of LP-BM5 MuLV (MAIDS mice) were treated intraperitoneally with a 10-mg/kg dose of Z-100 every other day beginning 1 day after the viral infection. MAIDS mice treated with Z-100 were compared with control mice (MAIDS mice treated with saline) for their survival and splenomegaly after LP-BM5 infection. Cytokine-producing profiles of splenic T cells from these two groups of mice were also compared. Results: When MAIDS mice treated with Z-100 were compared with those of control mice, a decrease in splenomegaly and lymphadenopathy was observed. Splenomegaly was markedly enhanced in MAIDS mice treated intraperitoneally with IL-4 or IL-10. When MAIDS mice were treated with Z-100, their survival rates were significantly increased compared to those of controls. Splenic T cells from control mice produced type-2 cytokines (IL-4 and IL-10). However, a decreased production of type-2 cytokines by splenic T cells from MAIDS mice treated with Z-100 was demonstrated. Conclusion: Z-100 could decrease the severity of the LP-BM5 MuLV infection through the regulation of MAIDS-associated type-2 T-cell responses.

KW - AIDS

KW - Murine AIDS

KW - Type-2 T-cell responses

KW - Z-100

UR - http://www.scopus.com/inward/record.url?scp=0035669377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035669377&partnerID=8YFLogxK

U2 - 10.1159/000048762

DO - 10.1159/000048762

M3 - Article

VL - 69

SP - 96

EP - 103

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 2

ER -